Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

i3 Health

Challenges and Opportunities in Metastatic Gastric Cancer

Access Activity

Overview / Abstract:

STATEMENT OF NEED

Gastric cancer is the third leading cause of cancer-related death worldwide. In the US, an estimated 27,510 new cases of gastric cancer are diagnosed annually, and 11,140 people die of the disease. Despite advances in prevention, diagnosis, and treatment, due to the molecular heterogeneity of gastric cancer, prognosis remains poor. The 5-year survival rate for all stages is 31%, with only 5% of those diagnosed with distant-stage disease surviving longer than 5 years. Given this poor prognosis and the fact that most gastric cancers are diagnosed at advanced stages, new screening and treatment strategies represent a significant unmet medical need.

TARGET AUDIENCE

Oncology physicians, oncology advanced practitioners, oncology nurses, and other health care professionals involved in the treatment of patients with gastric cancer.

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

1. Assess pathologic and molecular characteristics that can individualize treatment selection for patients with metastatic gastric cancer
2. Differentiate emerging efficacy and safety data on novel therapies for patients with metastatic gastric cancer
3. Apply strategies to monitor and manage adverse events associated with novel therapies for metastatic gastric cancer

Note: The learning objectives listed above apply to nurse practitioners and registered nurses in addition to physicians.

Expiration

Mar 18, 2020

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME

Format

Monograph, Online

Credits / Hours

1.0

Accreditation

ACCME, ANCC

Presenters / Authors / Faculty

Jaffer A. Ajani, MD (Chairperson)
Professor of Cancer Medicine
University of Texas MD Anderson Cancer Center

Allyson J. Ocean, MD
Associate Professor Clinical Medicine
Weill Cornell Medical College

Sponsors / Supporters / Grant Providers

This activity is supported by independent educational grants from Lilly and Taiho Oncology.

Keywords / Search Terms

i3 Health i3 Health, gastric cancer, esophagogastric cancer, gastrointestinal cancer, GI cancer, oncology, free cme, free ce, free cme ce, supportive care, ILNA points Free CE CME

Access Activity

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.